MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 4660 La Jolla Village Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mbracetrx.com
- Keywords
- of our purpose-built team working tirelessly to advance innovative #ADC therapies in oncology..
- HQ
- San Diego, California
Mbrace Therapeutics Questions
Mbrace Therapeutics's website is http://www.mbracetrx.com
Mbrace Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mbrace-therapeutics
Mbrace Therapeutics has
25 employees.
View email and phone details for 25
employees at Mbrace Therapeutics.
Mbrace Therapeutics's industry is
Biotechnology Research
Mbrace Therapeutics's top competitors are
T-Therapeutics Ltd,
Terremoto Biosciences,
Kynexis,
Vectory,
Orsobio,
Nouscom,
Gate Bioscience,
Blackbird Laboratories,
Eyebio,
Aro Biotherapeutics.
Mbrace Therapeutics's categories are Biotechnology Research
Mbrace Therapeutics's founding year is 2020
